Tamsulosin Hydrochloride Capsule
Product Images NDC 50090-4906

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 50090-4906). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500904906)

Tamsulosin Hydrochloride 0.4 mg capsules packaging label by A-S Medication Solutions. The label includes product NDC 50090-4906-0, dosage form as oral capsules, storage instructions to store at 77 degrees F and avoid excess moisture, and a package count of 90 capsules.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A line graph comparing plasma concentration (ng/mL) over time (hours) for Tamsulosin Hydrochloride under fasted and fed conditions. The graph shows plasma levels peaking earlier and higher in the fasted state, with both lines declining over 36 hours.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over treatment duration in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The graph plots mean change on the vertical axis against treatment duration on the horizontal axis, with data points and legends indicating the dosage groups.*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph depicting the mean change over duration of treatment in weeks for three groups: 0.8 mg dosage, 0.4 mg dosage of Tamsulosin Hydrochloride, and placebo. The x-axis represents treatment duration (0 to 13 weeks), and the y-axis shows mean change values, with each group's trend visualized by distinct line styles and markers.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph depicting mean change in a measured variable (mL/sec) over duration of treatment in weeks. Three treatment groups are compared: 0.8 mg, 0.4 mg, and placebo. The graph shows trends for each group across multiple time points up to 13 weeks and an additional LOCE measurement.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

A line graph showing the mean change in a certain measure (mL/sec) over the duration of treatment in weeks. The graph compares three treatment groups: 0.8 mg, 0.4 mg, and Placebo, with sample sizes indicated at various time points. The 0.8 mg group shows a rapid increase initially, then a decline, and stabilizes; the 0.4 mg group has a moderate rise and slight increase over time; the Placebo group shows a gradual increase throughout the treatment period.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular composition including a methoxy-substituted aromatic ring and hydrochloride component, as depicted in a structural formula diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.